Efficacy and Safety of VisuEvo® and Cationorm® for the Treatment of Evaporative and Non-Evaporative Dry Eye Disease: A Multicenter, Double-Blind, Cross-Over, Randomized Clinical Trial
Paolo Fogagnolo,1 Chiara Quisisana,1 Anna Caretti,2 Daniele Marchina,1 Michele Dei Cas,2 Ettore Melardi,1 Luca Rossetti1 1Eye Clinic ASST Santi Paolo Carlo, Department of Health Sciences, San Paolo Hospital, University of Milan, Milan, Italy; 2Department of Health Sciences, Laboratory of Biochemistr...
Enregistré dans:
Auteurs principaux: | Fogagnolo P, Quisisana C, Caretti A, Marchina D, Dei Cas M, Melardi E, Rossetti L |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fd3a2a7c065b42b3b272235e8a1c1afd |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Frequency and risk factors associated with dry eye in patients attending a tertiary care ophthalmology center in Mexico City
par: Martinez JD, et autres
Publié: (2016) -
Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial
par: Tauber J, et autres
Publié: (2020) -
Influence of bacterial burden on meibomian gland dysfunction and ocular surface disease
par: Nattis A, et autres
Publié: (2019) -
Ocular Surface Erosion after Suspected Exposure to Evaporated COVID-19 Vaccine
par: Somporn Chantra, et autres
Publié: (2021) -
Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma
par: Walimbe T, et autres
Publié: (2016)